Inhibition of activity tryptophan hydroxylase-1 - the new conception in the treatment of mineral and bone disorders in chronić reanal failure.
2013/09/B/NZ7/00046
Keywords
Descriptors
- NZ7_14: Farmacja, farmakoterapia, farmakologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej
Voivodeship: podlaskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 9
Call
OPUS 5 – announced on 2013-03-15
- Amount awarded
- 729 685 PLN
- Project start date
- 2014-03-21
- Project end date
- 2018-03-20
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project settled
Equipment purchased [PL]
- Aparat spektrofotometr UV-Vis NanoDrop2000.
- Oprogramowanie Biokinetica v.4.0. Cost: 9 000 PLN
- Zamrażarka niskotemperaturowa z awaryjnym systemem chłodzenia (CO2), pojemność 500 l, stelaże, pojemniki niskotemperaturowe.. Cost: 95 000 PLN
Information in the final report
Publication in academic press/journals (5)
-
Inhibition of peripheral serotonin synthesis by LP533401 and disturbances in calciotropic hormones attenuated excessive osteoblastogenesis with simultaneous improvement of bone mineral status in 5/6 nephrectomized rats.
- Authors:
- Pawlak D, Domaniewski T, Sieklucka B, Jakuc M, Pawlak K.
- Academic press:
- Biochim Biophys Acta Mol Basis Dis (year: 2019, volume: 1865, pages: 165528), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.bbadis.2019.08.004 – link to the publication
-
The association between elevated levels of peripheral serotonin and its metabolite - 5-hydroxyindoleacetic acid and bone strength and metabolism in growing rats with mild experimental chronic kidney disease
- Authors:
- Pawlak D, Oksztulska-Kolanek E, Znorko B, Domaniewski T, Rogalska J, Roszczenko A, Brzóska MM, Pryczynicz A, Kemona A, Pawlak K
- Academic press:
- PLoS One (year: 2016, volume: 2016;11(10), pages: -), Publisher: Public Limbrary of Science
- Status:
- Published
- DOI:
- 10.1371/journal.pone.0163526 – link to the publication
-
LP533401 restores bone health in 5/6 nephrectomized rats by a decrease of gut-derived serotonin and regulation of serum phosphate through the inhibition of phosphate co-transporters expression in the kidneys.
- Authors:
- Pawlak D, Znorko B, Kalaska B, Domaniewski T, Zawadzki R, Lipowicz P, Doroszko M, Łebkowska U, Grabowski P, Pawlak K
- Academic press:
- Bone (year: 2018, volume: 113, pages: 124-136), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.bone.2018.05.022 – link to the publication
-
The use of LP533401 as a therapeutic option for renal osteodystrophy affects, renal calcium handling, vitamin D metabolism, and bone health in uremic rats.
- Authors:
- Pawlak D, Domaniewski T, Znorko B, Pawlak K
- Academic press:
- Expert Opin Ther Targets (year: 2019, volume: 23, pages: 353-364), Publisher: Taylor & Francis Online
- Status:
- Published
- DOI:
- 10.1080/14728222.2019.1586883 – link to the publication
-
The impact of peripheral serotonin on leptin-brain serotonin axis, bone metabolism and strength in growing rats with experimental chronic kidney disease.
- Authors:
- Pawlak D, Domaniewski T, Znorko B, Oksztulska-Kolanek E, Lipowicz P, Doroszko M, Karbowska M, Pawlak K.
- Academic press:
- Bone (year: 2017, volume: 105, pages: 46032), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.bone.2017.08.004 – link to the publication
Articles in post-conference publications (8)
-
Tryptophan hydroxylase-1 inhibitor – LP533401 by decrease serum phosphorus affected bone mineral density in experimental chronic kidney disease
- Authors:
- Pawlak D, Znorko B, Zawadzki R, Łebkowska U, Domaniewski T, J Rogalska, Brzoska M, Pawlak K
- Conference:
- Osteoporosis Conference 2016, Birmingham, UK, 7-9 November 2016. (year: 2016, pages: S682), Publisher: Springer
- Date:
- conference 7-9 listopada 2016
- Status:
- Published
-
The treatment with LP533401 improved bone mineral density in rats with experimental chronic kidney disease.
- Authors:
- Pawlak K, Znorko B, Zawadzki R, Łebkowska U, Domaniewski T, Pawlak D
- Conference:
- Osteoporosis Conference 2016, Birmingham, UK, 7-9 November 2016. (year: 2016, pages: S682), Publisher: Springer
- Date:
- conference 7-9 listopad 2016
- Status:
- Published
-
Wpływ inhibitora hydroksylazy tryptofanu - LP533401 na gospodarkę witaminy D w doświadczalnym modelu niewydolności nerek u szczura.
- Authors:
- Pawlak D, Domaniewski T, Znorko B, Mor A, Pawlak K.
- Conference:
- XXIV Konferencja Naukowo-Szkoleniowa Polskiego Towarzystwa Nefrologicznego (year: 2018, pages: .), Publisher: Polskie Towarzystwo Nefrologiczne
- Date:
- conference 21-23 czerwiec
- Status:
- Published
-
Wpływ terapii LP533401 na ekspresję transporterów wapnia w nerce w modelu eksperymentalnej niewydolności nerek u szczura.
- Authors:
- Pawlak K, Domaniewski T, Znorko B, Grabowski P, Pawlak D.
- Conference:
- XXIV Konferencja Naukowo-Szkoleniowa Polskiego Towarzystwa Nefrologicznego (year: 2018, pages: .), Publisher: Polskie Towarzystwo Nefrologiczne
- Date:
- conference 21-23 czerwiec
- Status:
- Published
-
LP533401 treatment and disturbance of calciotropic hormones resulted in dysregulation of serotonin-dependent genes and reduction of osteoblast proliferation/differentiation in rats with chronic kidney disease.
- Authors:
- Pawlak K, Domaniewski T, Sieklucka B, Jakuc M, Pawlak D
- Conference:
- 7th Central European Congress on Osteoporosis and Osteoarthritis (year: 2019, pages: 165-166), Publisher: Komitet Organizacyjny Kongresu
- Date:
- conference 27-28 wrzesień
- Status:
- Published
-
The influence of tryptophan hydroxylase inhibitor LP533401 on kynurenine concentration in bone tissue in the experimental model of chronic kidney disease.
- Authors:
- Kalaska B, Mor A, Sieklucka B, Domaniewski T, Zawadzki R, Lebkowska U, Pawlak K, Pawlak D
- Conference:
- 56th ERA-EDTA Congress (year: 2019, pages: .), Publisher: Nephrol Dial Transplant 2019, 34 (suppl.1), FP443
- Date:
- conference 13-16 czerwiec
- Status:
- Published
- DOI:
- link to the publication
-
Wpływ LP533401 na wydalanie fosforanów i ekspresję genów zaangażowanych w reabsorpcję fosforanów w nerce w modelu eksperymentalnej niewydolności nerek u szczura.
- Authors:
- Pawlak K, Domaniewski T, Znorko B, Pawlak D.
- Conference:
- XXIII Naukowy Zjazd Polskiego Towarzystwa Farmaceutycznego (year: 2017, pages: 44), Publisher: Polskie Towarzystwo Farmaceutyczne, Wydział Farmaceutyczny, Uniwersytet Jagielloński-Collegium Medicum
- Date:
- conference 19-22 wrzesień
- Status:
- Published
-
Low expression of sclerostin (Sost) gene in the femur of rats with chronic kidney disease treated with inhibitor of type 1 tryptophan hydroxylase is associated with the improvement of femoral mineral status.
- Authors:
- Pawlak D, Domaniewski T, Sieklucka B, Jakuc M, Pawlak K.
- Conference:
- 7th Central European Congress on Osteoporosis and Osteoarthritis (year: 2019, pages: 169-170), Publisher: Komitet Organizacyjny Kongresu
- Date:
- conference 27-28 września
- Status:
- Published